iMedica Company Overview, Contact Details & Competitors

Insights

Gathering insights about iMedica…

Similar companies to iMedica

iMedica Tech Stack

iMedica uses 8 technology products and services including Google Ads, SAP HANA, Spring Boot, and more. Explore iMedica's tech stack below.

Google Ads
Advertising
SAP HANA
Database Management
Spring Boot
Frameworks And Libraries
Azure Active Directory
Identity And Access Management
Redux
Javascript Frameworks
JSON
Programming Languages
Microsoft Defender
Security
Miro
Team Collaboration

Media & News

CalciMedica Announces Presentations at Upcoming Medical Meetings
LA JOLLA, Calif. , April 17, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the acceptance of an abstract for poster presentation at Digestive Disease Week (DDW) 2025 being held May 3-6 in San Diego, CA, and the participation of Sudarshan Hebbar, M.D.
Apr 17, 2025 | www.prnewswire.com
CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade
CalciMedica Inc. (CALC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Apr 02, 2025 | www.zacks.com
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference
LA JOLLA, Calif. , April 1, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D.
Apr 01, 2025 | www.prnewswire.com
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates
Enrollment ongoing in Phase 2 KOURAGE trial of Auxora™ in acute kidney injury (AKI) and respiratory failure; data expected around the end of 2025 Post-hoc analysis of subset of patients with AKI in the Phase 2 CARDEA trial of Auxora in severe COVID-19 pneumonia showed a 62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated with Auxora versus placebo Cash position expected to fund operations into mid-2026 LA JOLLA, Calif. , March 27, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today reported financial results for the year ended December 31, 2024 and provided clinical and corporate updates.
Mar 27, 2025 | www.prnewswire.com
CalciMedica Secures Credit Facility for Up to $32.5 Million
$10 million funded at close extends cash runway into mid-2026 LA JOLLA, Calif. , March 5, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that the Company has entered into a credit facility with Avenue Venture Opportunities Fund II, L.P.
Mar 05, 2025 | www.prnewswire.com
CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference
62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated with Auxora versus placebo in subset of patients in CARDEA with AKI LA JOLLA, Calif. , March 4, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Sudarshan Hebbar, M.D.
Mar 04, 2025 | www.prnewswire.com
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference
LA JOLLA, Calif. , Feb. 19, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced a plenary presentation at the 30th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference (AKI & CRRT) being held March 3-6, 2025 in San Diego, CA.
Feb 19, 2025 | www.prnewswire.com

iMedica's Email Address Formats

iMedica uses at least 2 format(s):

iMedica Email Formats	Example	Percentage
FLast@aprima.com	JDoe@aprima.com	85%
Last@aprima.com	Doe@aprima.com	6%
First_Last@aprima.com	John_Doe@aprima.com	3%
Last_First@aprima.com	Doe_John@aprima.com	2%
FirLast@aprima.com	JohDoe@aprima.com	1%
LastFirst@aprima.com	DoeJohn@aprima.com	1%
LastF@aprima.com	DoeJ@aprima.com	1%
First.Last@aprima.com	John.Doe@aprima.com	1%
First.Last@cgm.com	John.Doe@cgm.com	99%
FirstLast@cgm.com	JohnDoe@cgm.com	1%

Frequently Asked Questions

Where is iMedica's headquarters located?

iMedica's main headquarters is located at US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is iMedica's phone number?

You can contact iMedica's main corporate office by phone at

+1-214-466-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is iMedica's stock symbol?

iMedica is a publicly traded company; the company's stock symbol is CALC.

What is iMedica's official website and social media links?

iMedica's official website is cgm.com and has social profiles on LinkedIn.

What is iMedica's NAICS code?

iMedica's NAICS code is 5112 - Software Publishers.

How many employees does iMedica have currently?

As of May 2025, iMedica has approximately 201 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: J. H.Vice President Implementations: C. B.Manager Of Project Management: D. F.. Explore iMedica's employee directory with LeadIQ.

What industry does iMedica belong to?

iMedica operates in the Software Development industry.

What technology does iMedica use?

iMedica's tech stack includes Google AdsSAP HANASpring BootAzure Active DirectoryReduxJSONMicrosoft DefenderMiro.

What is iMedica's email format?

iMedica's email format typically follows the pattern of . Find more iMedica email formats with LeadIQ.

Insights

Similar companies to iMedica

athenahealth

NextGen Healthcare

CareCloud

EPIC Systems, Incorporated

Greenway Health

eClinicalWorks

iMedica Tech Stack

Media & News

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Secures Credit Facility for Up to $32.5 Million

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

iMedica's Email Address Formats

Frequently Asked Questions

Where is iMedica's headquarters located?

What is iMedica's phone number?

What is iMedica's stock symbol?

What is iMedica's official website and social media links?

What is iMedica's NAICS code?

How many employees does iMedica have currently?

What industry does iMedica belong to?

What technology does iMedica use?

What is iMedica's email format?

iMedica

Company Overview

Media & News

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?